Director Richard J. Daly buys 28,025 Aquestive Therapeutics (AQST) shares on the open market.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Aquestive Therapeutics, Inc. director Richard J. Daly reported purchasing 28,025 shares of common stock on November 10, 2026, through two direct open-market transactions. He bought 1,200 shares at $3.53 each and 26,825 shares at $3.545 each. Following these transactions, Daly's direct holdings in common stock increased from 0 to 28,025 shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.